1.Impact of Sleep Duration on Emotional Status in Adolescents.
Jungjin LEE ; Jeonghee KANG ; Seonkyeong RHIE ; Kyu Young CHAE
Journal of the Korean Child Neurology Society 2013;21(3):100-110
PURPOSE: South Korean adolescents have been identified as a chronic partial sleep-deprived population in several previous studies. This study was to identify the current nocturnal sleep duration by age in South Korean adolescents and to analyze the association of emotional status factors such as subjective happiness, depression and suicidal attempts, and health-risk behaviors with the nocturnal sleep duration. METHODS: The findings in this study are based on the data obtained from the 7th Korea Youth Risk Behavior Web-Based Survey (KYRBWS-VII), a cross-sectional, annual survey of the health-risk behaviors in a representative sample of South Korean middle- and high-school students aged 13-18 years, which was conducted in 2011. Out of 75,643 students from 800 schools across the nation, 75,205 students were selected by using the complex sampling design of the survey. We analyzed the relationships between the duration of nocturnal sleep and emotional status (subjective happiness, stress level, depression, and suicidal thoughts), health-risk behaviors (smoking, drinking), and sleep satisfaction. RESULTS: There was a significant relationship between the duration of sleep and the emotional status. In general, happy students had the longest nocturnal sleep duration, regardless of their grades. Self-rated stress levels and depression in adolescents were inversely proportional to nocturnal sleep duration. Health-risk behaviors such as smoking and alcohol consumptions were more common in sleep-deprived students (P<0.001). CONCLUSION: Appropriate nocturnal sleep duration is critical for emotional health as well as prevention of suicide in the adolescent population.
Adolescent*
;
Depression
;
Happiness
;
Humans
;
Korea
;
Risk-Taking
;
Sleep Deprivation
;
Smoke
;
Smoking
;
Suicidal Ideation
;
Suicide
2.A Case of Combined Acute Disseminated Encephalomyelitis and Acute Flaccid Paralysis associated with Enteroviral Infection.
Jungjin LEE ; Youjin CHOI ; Seonkyeong RHIE ; Sun Jung JANG ; Kyu Young CHAE
Journal of the Korean Child Neurology Society 2013;21(3):208-212
Enterovirus infection is often aggravated and manifests as various neurological complications such as aseptic meningitis, brainstem encephalitis, poliomyelitis-like acute flaccid paralysis, transverse myelitis, and severe systemic diseases. There are a few reports indicating that enterovirus is associated with acute disseminated encephalomyelitis (ADEM), acute flaccid paralysis, or Guillain-Barre syndrome separately. However, none of these report ADEM and acute flaccid paralysis occurring simultaneously. Here, we present a case of combined ADEM and acute flaccid paralysis associated with enteroviral infection in a child and reviewed the relevant literature. A 5-year-old boy was admitted to the hospital for headache and vomiting with evident meningeal irritation signs. Despite of antibiotic therapy, his mental state rapidly declined to coma with abnormal upper motor neuron (UMN) signs. During 5 consecutive days of steroid pulse therapy, his abnormal UMN signs abruptly changed to flaccid paralysis. Suspected acute flaccid paralysis due to enterovirus prompted the addition of intravenous immunoglobulin (IVIG). On hospital day 33, he was discharged with full recovery of muscle tone and strength with an alert mental state.
Attention Deficit Disorder with Hyperactivity
;
Brain Stem
;
Child
;
Child, Preschool
;
Coma
;
Encephalitis
;
Encephalomyelitis
;
Encephalomyelitis, Acute Disseminated*
;
Enterovirus
;
Enterovirus Infections
;
Guillain-Barre Syndrome
;
Headache
;
Humans
;
Immunoglobulins
;
Male
;
Meningitis, Aseptic
;
Motor Neurons
;
Muscle Hypotonia
;
Muscles
;
Myelitis, Transverse
;
Paralysis*
;
Vomiting
3.Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs
Sungyeun BAE ; JungJin OH ; Ildae SONG ; Kyung-Sang YU ; SeungHwan LEE
Translational and Clinical Pharmacology 2022;30(3):145-154
Obesity has been a growing worldwide concern, and surgical intervention including bariatric surgery is considered as one of the options for treatment. However, there still is controversy over the change in pharmacokinetics (PKs) of drugs after the surgery. To investigate the potential covariates that can influence the area under the curve (AUC) and maximum plasma concentration (Cmax), the design of previous studies was reviewed based on pre-determined eligibility criteria. Each study calculated the ratios of the AUC and Cmax before and after bariatric surgery. These studies investigated whether the PK parameters were affected by the time after the surgery or by the type of control group. The ratio of the AUC calculated in the early and late follow-up period was similar across Roux-en Y gastric bypass patients. No significant difference in the PK parameters was found between the pre-surgical patients and matched healthy subjects. However, certain control groups could be preferable depending on the purpose of the clinical trial. Although Cmax was inconsistent compared to the AUC, insufficient sampling of the time points may have caused such an inconsistency. This is the first article exploring the appropriate methodology in designing clinical studies for changes in the PK characteristics of orally administered drugs in patients with bariatric surgery.
4.Effects of rifampin coadministration on the pharmacokinetics of digoxin: a real-world data approach
JungJin OH ; Byungwook KIM ; SeungHwan LEE
Translational and Clinical Pharmacology 2023;31(3):148-153
Digoxin, a cardiac glycoside, is commonly prescribed to treat heart failure and atrial fibrillation. Because digoxin acts as a substrate of P-glycoprotein (P-gp), its blood concentration may be reduced by P-gp inducers such as rifampin. To assess the real-world implications of this drug-drug interaction, a retrospective analysis was carried out on the Clinical Data Warehouse at Seoul National University Hospital between 2012 and 2017. Eleven patients who received both digoxin and rifampin with satisfying the inclusion/exclusion criteria were identified. The C trough values of digoxin monotherapy were compared to those of the combination therapy with rifampin. Results demonstrated that the systemic exposure of orally administered digoxin decreased by 40% with the concurrent use of rifampin. Clinicians should be aware of potential drug interactions between digoxin and rifampin, as adjustments to digoxin dosage might be necessary for patients receiving rifampin or other P-gp inducer drugs.
5.A Case of Cushing Syndrome Diagnosed by Recurrent Pathologic Fractures in a Young Woman.
Ju Young HAN ; Jungjin LEE ; Gyung Eun KIM ; Jin Yeob YEO ; So Hun KIM ; Moonsuk NAM ; Yong Seong KIM ; Seongbin HONG
Journal of Bone Metabolism 2012;19(2):153-158
Cushing's syndrome is characterized by central obesity, fatigability, weakness, amenorrhea, hirsutism, edema, hypertension, impaired glucose tolerance, and osteoporosis due to excessive production of steroids. Cushing's syndrome is an important cause of secondary osteoporosis. Patients with Cushing's syndrome have a high incidence of osteoporotic fractures. At least, 30-50% of patients with Cushing's syndrome experience fractures, particularly in the vertebral body. And it is consistent with the 50% prevalence of osteoporosis in patients with Cushing's syndrome. However, reports of multiple pathological fractures in young patients with Cushing's syndrome are rare. Thus, we describe the case of a 26-year-old woman with Cushing's syndrome accompanied with recurrent multiple osteoporotic fractures and being treated by parathyroid hormone. Careful consideration for the possibility of Cushing's syndrome will be necessary in case of young patients with a spontaneous multiple compression fractures in spine.
Adult
;
Amenorrhea
;
Cushing Syndrome
;
Edema
;
Female
;
Fractures, Compression
;
Fractures, Spontaneous
;
Glucose
;
Hirsutism
;
Humans
;
Hypertension
;
Incidence
;
Obesity, Abdominal
;
Osteoporosis
;
Osteoporotic Fractures
;
Parathyroid Hormone
;
Prevalence
;
Spine
;
Steroids